HeraMED CEO Steps Down CFO Transitions to EVP Role Shares Surge 33 percent - Marketscreener.com
| 041920 Stock | KRW 5,100 10.00 0.20% |
About 62% of MEDIANA CoLtd's investor base is looking to short. The analysis of current outlook of investing in MEDIANA CoLtd suggests that many traders are alarmed regarding MEDIANA CoLtd's prospects. The current market sentiment, together with MEDIANA CoLtd's historical and current headlines, can help investors time the market. In addition, many technical investors use MEDIANA CoLtd stock news signals to limit their universe of possible portfolio assets.
MEDIANA |
HeraMED CEO Steps Down CFO Transitions to EVP Role Shares Surge 33 Marketscreener.com
Read at news.google.com
 |
MEDIANA CoLtd Fundamental Analysis
We analyze MEDIANA CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MEDIANA CoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MEDIANA CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
MEDIANA CoLtd is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
MEDIANA CoLtd Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MEDIANA CoLtd stock to make a market-neutral strategy. Peer analysis of MEDIANA CoLtd could also be used in its relative valuation, which is a method of valuing MEDIANA CoLtd by comparing valuation metrics with similar companies.
Peers
MEDIANA CoLtd Related Equities
| 041190 | Woori Technology | 8.66 | ||||
| 298380 | ABL Bio | 1.47 | ||||
| 029780 | Samsung Card | 0.35 | ||||
| 036030 | KT Hitel | 0.53 | ||||
| 065660 | AnterogenCoLtd | 3.83 | ||||
| 293780 | AptaBio Therapeutics | 4.91 | ||||
| 215600 | SillaJen | 9.24 | ||||
| 217330 | Cytogen | 9.38 |
Complementary Tools for MEDIANA Stock analysis
When running MEDIANA CoLtd's price analysis, check to measure MEDIANA CoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIANA CoLtd is operating at the current time. Most of MEDIANA CoLtd's value examination focuses on studying past and present price action to predict the probability of MEDIANA CoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIANA CoLtd's price. Additionally, you may evaluate how the addition of MEDIANA CoLtd to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |